UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
CEMIG Preferred Shares
CIG
$6.15B
| $313K | ﹤0.01% |
+151,900
| New | +$303K |
|
2652
Invesco S&P International Developed Low Volatility ETF
IDLV
$347M
| $311K | ﹤0.01% |
+10,231
| New | +$298K |
|
2653
Ibotta
IBTA
$625M
| $308K | ﹤0.01% |
+5,007
| New | +$303K |
|
2654
Movado Group
MOV
$846M
| $307K | ﹤0.01% |
16,494
-21,258
| -56% | -$489K |
|
2655
OrthoPediatrics
KIDS
$517M
| $305K | ﹤0.01% |
11,232
-2,588
| -19% | -$78.4K |
|
|
OLPX
2656
DELISTED
Olaplex Holdings
OLPX
| $302K | ﹤0.01% |
128,338
-50,799
| -28% | -$103K |
|
2657
Ginkgo Bioworks
DNA
$515M
| $295K | ﹤0.01% |
36,249
-11,291
| -24% | -$113K |
|
2658
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $295K | ﹤0.01% |
8,000
| – | – |
|
|
OBE
2659
Obsidian Energy
OBE
$654M
| $283K | ﹤0.01% |
51,092
-73,519
| -59% | -$493K |
|
2660
Westrock Coffee
WEST
$821M
| $279K | ﹤0.01% |
42,879
-4,036
| -9% | -$35.5K |
|
|
SENEB
2661
Seneca Foods Class B
SENEB
| $278K | ﹤0.01% |
4,500
| – | – |
|
2662
Astera Labs
ALAB
$44.7B
| $277K | ﹤0.01% |
5,284
+284
| +6% | +$13.3K |
|
2663
Excelerate Energy
EE
$1.19B
| $276K | ﹤0.01% |
12,541
-4,954
| -28% | -$96K |
|
2664
Lyell Immunopharma
LYEL
$319M
| $270K | ﹤0.01% |
9,795
+165
| +2% | +$4.85K |
|
2665
Savers
SVV
$1.54B
| $252K | ﹤0.01% |
+23,939
| New | +$244K |
|
2666
Ternium
TX
$9.54B
| $251K | ﹤0.01% |
6,800
| – | – |
|
2667
NVE Corp
NVEC
$555M
| $240K | ﹤0.01% |
3,000
| – | – |
|
2668
Oric Pharmaceuticals
ORIC
$1.19B
| $236K | ﹤0.01% |
23,034
-19,286
| -46% | -$191K |
|
2669
Boston Omaha
BOC
$436M
| $235K | ﹤0.01% |
15,787
-3,803
| -19% | -$53K |
|
|
NYAX
2670
Nayax
NYAX
$2.58B
| $228K | ﹤0.01% |
9,040
-317
| -3% | -$7.5K |
|
2671
Entrada Therapeutics
TRDA
$259M
| $226K | ﹤0.01% |
14,156
+3,644
| +35% | +$57.4K |
|
|
ENFN
2672
DELISTED
Enfusion, Inc.
ENFN
| $223K | ﹤0.01% |
23,548
-57
| -0.2% | -$492 |
|
2673
Bitdeer Technologies
BTDR
$2.23B
| $220K | ﹤0.01% |
+28,072
| New | +$233K |
|
2674
Centuri Holdings
CTRI
$2.5B
| $211K | ﹤0.01% |
+13,086
| New | +$227K |
|
|
EVV
2675
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $210K | ﹤0.01% |
20,000
-15,000
| -43% | -$151K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.